Zura Bio Limited (ZURA)

HashiCorp Statistics

Total Valuation

Zura Bio has a market cap or net worth of $92.81 million. The enterprise value is -$77.76 million.

Market Cap	92.81M
Enterprise Value	-77.76M

Important Dates

The next estimated earnings date is Friday, August 15, 2025, before market open.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Zura Bio has 61.87 million shares outstanding. The number of shares has increased by 97.21% in one year.

Current Share Class	61.87M
Shares Outstanding	61.87M
Shares Change (YoY)	+97.21%
Shares Change (QoQ)	+2.22%
Owned by Insiders (%)	7.26%
Owned by Institutions (%)	43.77%
Float	24.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.74
P/TBV Ratio	0.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.14

Current Ratio	8.14
Quick Ratio	8.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -55.05% and return on invested capital (ROIC) is -36.60%.

Return on Equity (ROE)	-55.05%
Return on Assets (ROA)	-31.40%
Return on Invested Capital (ROIC)	-36.60%
Return on Capital Employed (ROCE)	-43.63%
Revenue Per Employee	n/a
Profits Per Employee	-$2.07M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.03% in the last 52 weeks. The beta is -0.06, so Zura Bio's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	-62.03%
50-Day Moving Average	1.27
200-Day Moving Average	1.97
Relative Strength Index (RSI)	53.14
Average Volume (20 Days)	990,135

Short Selling Information

The latest short interest is 585,928, so 0.95% of the outstanding shares have been sold short.

Short Interest	585,928
Short Previous Month	1.16M
Short % of Shares Out	0.95%
Short % of Float	2.37%
Short Ratio (days to cover)	0.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-66.06M
Pretax Income	-58.52M
Net Income	-62.10M
EBITDA	n/a
EBIT	-66.06M
Earnings Per Share (EPS)	-$0.72

Balance Sheet

The company has $170.57 million in cash and n/a in debt, giving a net cash position of $170.57 million or $2.76 per share.

Cash & Cash Equivalents	170.57M
Total Debt	n/a
Net Cash	170.57M
Net Cash Per Share	$2.76
Equity (Book Value)	151.40M
Book Value Per Share	2.02
Working Capital	150.60M

Cash Flow

In the last 12 months, operating cash flow was -$34.16 million and capital expenditures -$117,000, giving a free cash flow of -$34.27 million.

Operating Cash Flow	-34.16M
Capital Expenditures	-117,000
Free Cash Flow	-34.27M
FCF Per Share	-$0.55

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zura Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.21%
Shareholder Yield	-97.21%
Earnings Yield	-66.91%
FCF Yield	-36.93%

Analyst Forecast

The average price target for Zura Bio is $14.33, which is 855.33% higher than the current price. The consensus rating is "Buy".

Price Target	$14.33
Price Target Difference	855.33%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2